Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit - manually
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit - manually
Asym./Biol. Unit - manually  (Jmol Viewer)
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  INSULIN RECEPTOR (DOMAINS 1-3)
 
Authors :  T. P. J. Garrett, C. W. Ward
Date :  19 Jul 06  (Deposition) - 15 Aug 06  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.32
Chains :  Asym./Biol. Unit :  A,B
Keywords :  Hormone Receptor, Leucine Rich Repeat, Transferase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  M. Lou, T. P. Garrett, N. M. Mckern, P. A. Hoyne, V. C. Epa, J. D. Bentley, G. O. Lovrecz, L. J. Cosgrove, M. J. Frenkel, C. W. Ward
The First Three Domains Of The Insulin Receptor Differ Structurally From The Insulin-Like Growth Factor 1 Receptor In The Regions Governing Ligand Specificity.
Proc. Natl. Acad. Sci. Usa V. 103 12429 2006
PubMed-ID: 16894147  |  Reference-DOI: 10.1073/PNAS.0605395103

(-) Compounds

Molecule 1 - INSULIN RECEPTOR
    ChainsA, B
    EC Number2.7.1.112
    EngineeredYES
    Expression SystemCRICETULUS GRISEUS
    Expression System CommonCHINESE HAMSTER
    Expression System PlasmidPEE14-IR485
    Expression System StrainLEC8
    Expression System Taxid10029
    Expression System Vector TypePLASMID
    FragmentDOMAINS 1-3 (RESIDUES 28-512)
    GeneINSR
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (7, 76)

Asymmetric/Biological Unit (7, 76)
No.NameCountTypeFull Name
1BMA6Ligand/IonBETA-D-MANNOSE
2FUC6Ligand/IonALPHA-L-FUCOSE
3GOL19Ligand/IonGLYCEROL
4MAN10Ligand/IonALPHA-D-MANNOSE
5NAG26Ligand/IonN-ACETYL-D-GLUCOSAMINE
6P331Ligand/Ion3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL
7SO48Ligand/IonSULFATE ION

(-) Sites  (76, 76)

Asymmetric Unit (76, 76)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREASN A:15 , ASN A:16 , HOH A:778BINDING SITE FOR RESIDUE NAG A 501
02AC2SOFTWAREHIS A:21 , GLU A:24 , ASN A:25 , NAG A:512BINDING SITE FOR RESIDUE NAG A 511
03AC3SOFTWARENAG A:511BINDING SITE FOR RESIDUE NAG A 512
04AC4SOFTWAREASN A:111 , SER A:134 , ARG A:135 , ILE A:136 , LEU A:137 , ASP A:138 , LEU A:213 , ARG A:229 , NAG A:532 , GOL A:587 , HOH A:615BINDING SITE FOR RESIDUE NAG A 531
05AC6SOFTWAREASP A:138 , NAG A:531 , BMA A:533BINDING SITE FOR RESIDUE NAG A 532
06AC7SOFTWARENAG A:532 , MAN A:534 , MAN A:535 , MAN A:536BINDING SITE FOR RESIDUE BMA A 533
07AC8SOFTWAREARG A:114 , BMA A:533 , MAN A:535 , GOL A:584BINDING SITE FOR RESIDUE MAN A 534
08AC9SOFTWARELYS A:283 , BMA A:533 , MAN A:534BINDING SITE FOR RESIDUE MAN A 535
09AD1SOFTWAREBMA A:533BINDING SITE FOR RESIDUE MAN A 536
10AD2SOFTWARENAG A:553 , SER B:467BINDING SITE FOR RESIDUE BMA A 554
11AD3SOFTWAREHIS A:313 , NAG A:571 , NAG A:573 , GLN B:177BINDING SITE FOR RESIDUE FUC A 572
12AD4SOFTWARENAG A:571 , FUC A:572BINDING SITE FOR RESIDUE NAG A 573
13AD5SOFTWARENAG A:591 , FUC A:592BINDING SITE FOR RESIDUE NAG A 593
14AD6SOFTWAREASN B:111 , SER B:134 , LEU B:137 , ASP B:138 , SER B:198 , LEU B:213 , NAG B:532 , HOH B:621 , HOH B:799 , HOH B:990BINDING SITE FOR RESIDUE NAG B 531
15AD7SOFTWAREASP B:138 , NAG B:531 , BMA B:533BINDING SITE FOR RESIDUE NAG B 532
16AD8SOFTWARENAG B:532 , MAN B:534 , MAN B:536BINDING SITE FOR RESIDUE BMA B 533
17AD9SOFTWAREASN B:108 , LYS B:190 , ASN B:215 , VAL B:226 , NAG B:542 , HOH B:890BINDING SITE FOR RESIDUE NAG B 541
18AE1SOFTWARENAG B:542 , MAN B:544 , MAN B:547BINDING SITE FOR RESIDUE BMA B 543
19AE2SOFTWAREBMA B:543BINDING SITE FOR RESIDUE MAN B 544
20AE3SOFTWAREASN A:123 , LEU A:147 , ASN A:148 , LYS A:149 , ASN A:152 , HOH A:701 , HOH A:777BINDING SITE FOR RESIDUE GOL A 612
21BC1SOFTWAREASN A:108 , LYS A:190 , ASN A:215 , VAL A:226 , NAG A:542 , GOL A:599 , HOH A:634 , HOH A:650 , HOH A:771BINDING SITE FOR RESIDUE NAG A 541
22BC2SOFTWAREASN A:78 , NAG A:541 , BMA A:543 , GOL A:599BINDING SITE FOR RESIDUE NAG A 542
23BC3SOFTWARENAG A:542BINDING SITE FOR RESIDUE BMA A 543
24BC4SOFTWAREASN A:255 , FUC A:552 , NAG A:553 , SO4 A:608 , HOH A:643 , ASP B:464 , LYS B:465BINDING SITE FOR RESIDUE NAG A 551
25BC5SOFTWAREASP A:234 , TYR A:245 , CYS A:253 , NAG A:551 , NAG A:553 , HOH A:627 , HOH A:639 , HOH A:694 , ASP B:464BINDING SITE FOR RESIDUE FUC A 552
26BC6SOFTWARENAG A:551 , FUC A:552 , BMA A:554 , SO4 A:608 , LYS B:465 , ALA B:466 , SER B:467BINDING SITE FOR RESIDUE NAG A 553
27BC8SOFTWAREHIS A:313 , ASN A:337 , GLU A:391 , FUC A:572 , NAG A:573BINDING SITE FOR RESIDUE NAG A 571
28CC2SOFTWAREASN A:397BINDING SITE FOR RESIDUE NAG A 581
29CC3SOFTWAREASN A:418 , THR A:420 , FUC A:592 , NAG A:593BINDING SITE FOR RESIDUE NAG A 591
30CC4SOFTWARENAG A:591 , NAG A:593BINDING SITE FOR RESIDUE FUC A 592
31CC6SOFTWAREGLU B:24 , ASN B:25BINDING SITE FOR RESIDUE NAG B 511
32CC7SOFTWAREASN B:397BINDING SITE FOR RESIDUE NAG B 581
33DC2SOFTWAREBMA B:533 , MAN B:535 , HOH B:741BINDING SITE FOR RESIDUE MAN B 534
34DC3SOFTWAREMAN B:534BINDING SITE FOR RESIDUE MAN B 535
35DC4SOFTWAREBMA B:533BINDING SITE FOR RESIDUE MAN B 536
36DC6SOFTWARENAG B:541 , BMA B:543BINDING SITE FOR RESIDUE NAG B 542
37DC9SOFTWAREBMA B:543 , MAN B:548 , MAN B:549BINDING SITE FOR RESIDUE MAN B 547
38EC1SOFTWAREMAN B:547BINDING SITE FOR RESIDUE MAN B 548
39EC2SOFTWAREILE A:279 , ASN A:281 , ASN A:282 , LEU A:300 , MAN B:547BINDING SITE FOR RESIDUE MAN B 549
40EC3SOFTWAREASN B:255 , FUC B:552 , NAG B:553 , HOH B:979BINDING SITE FOR RESIDUE NAG B 551
41EC4SOFTWAREARG B:252 , NAG B:551 , NAG B:553 , HOH B:847BINDING SITE FOR RESIDUE FUC B 552
42EC5SOFTWARENAG B:551 , FUC B:552 , BMA B:554BINDING SITE FOR RESIDUE NAG B 553
43EC6SOFTWARENAG B:553BINDING SITE FOR RESIDUE BMA B 554
44EC7SOFTWAREHIS B:313 , ASN B:337 , GLU B:363 , ARG B:389 , GLU B:391 , FUC B:572 , NAG B:573BINDING SITE FOR RESIDUE NAG B 571
45EC8SOFTWARENAG B:571 , NAG B:573BINDING SITE FOR RESIDUE FUC B 572
46EC9SOFTWARENAG B:571 , FUC B:572BINDING SITE FOR RESIDUE NAG B 573
47FC1SOFTWAREARG B:386 , ASN B:418 , THR B:420 , FUC B:592 , NAG B:593BINDING SITE FOR RESIDUE NAG B 591
48FC2SOFTWAREARG B:386 , NAG B:591BINDING SITE FOR RESIDUE FUC B 592
49FC3SOFTWARENAG B:591BINDING SITE FOR RESIDUE NAG B 593
50FC4SOFTWARESER A:85 , ARG A:86 , LEU A:87 , ARG A:114 , HOH A:749BINDING SITE FOR RESIDUE SO4 A 601
51FC5SOFTWAREARG A:236 , ASN A:343 , ARG A:345 , ARG A:371 , ARG A:372 , HOH A:790 , ARG B:454BINDING SITE FOR RESIDUE SO4 A 602
52FC6SOFTWARELYS A:369 , ARG A:371 , HOH A:658 , HOH A:682 , HOH A:703 , HOH A:740 , HOH A:792BINDING SITE FOR RESIDUE SO4 A 603
53FC7SOFTWAREPRO A:160 , GLY A:161 , THR A:162 , ALA A:163 , LYS A:164 , HIS A:185BINDING SITE FOR RESIDUE SO4 A 605
54FC8SOFTWAREGLU A:318 , LYS A:319 , THR A:320 , HOH A:662 , HOH A:762BINDING SITE FOR RESIDUE SO4 A 607
55FC9SOFTWARESER A:257 , NAG A:551 , NAG A:553 , HOH A:761 , LYS B:465BINDING SITE FOR RESIDUE SO4 A 608
56GC1SOFTWARESER B:85 , ARG B:86 , LEU B:87 , ARG B:114BINDING SITE FOR RESIDUE SO4 B 604
57GC2SOFTWAREASP B:221 , ARG B:236 , ASN B:343 , ARG B:345 , ARG B:371 , ARG B:372BINDING SITE FOR RESIDUE SO4 B 606
58GC3SOFTWAREPHE A:39 , LYS A:40 , PHE A:96 , ARG B:14 , PHE B:89BINDING SITE FOR RESIDUE P33 A 609
59GC4SOFTWAREPRO A:43 , PHE A:46 , ARG A:47 , GLY A:68 , LEU A:69 , GLU A:70 , SER A:71BINDING SITE FOR RESIDUE GOL A 610
60GC5SOFTWARECYS A:207 , ASP A:220 , ILE A:395 , TYR A:401 , HOH A:714BINDING SITE FOR RESIDUE GOL A 582
61GC6SOFTWAREGLU A:239 , THR A:240 , HOH A:654BINDING SITE FOR RESIDUE GOL A 583
62GC7SOFTWAREARG A:114 , MAN A:534BINDING SITE FOR RESIDUE GOL A 584
63GC8SOFTWAREGLU A:70 , LYS A:102 , PRO B:243BINDING SITE FOR RESIDUE GOL A 585
64GC9SOFTWARESER A:134 , ARG A:135 , LYS A:197 , SER A:198 , NAG A:531BINDING SITE FOR RESIDUE GOL A 587
65HC1SOFTWAREARG A:65 , GLU A:97 , LYS A:121 , ASN A:123 , GOL A:596BINDING SITE FOR RESIDUE GOL A 611
66HC3SOFTWAREPRO A:222 , THR A:223 , CYS A:225 , VAL A:226 , TYR A:232 , CYS A:237BINDING SITE FOR RESIDUE GOL A 594
67HC4SOFTWAREARG A:135 , THR A:172 , ARG A:181 , HOH A:686BINDING SITE FOR RESIDUE GOL A 595
68HC5SOFTWAREARG A:65 , GOL A:611 , ARG B:14BINDING SITE FOR RESIDUE GOL A 596
69HC6SOFTWAREGLU A:204 , HIS A:429 , TYR A:430 , ALA A:458 , THR A:461 , HOH A:746BINDING SITE FOR RESIDUE GOL A 597
70HC7SOFTWARENAG A:541 , NAG A:542BINDING SITE FOR RESIDUE GOL A 599
71HC8SOFTWAREPRO B:222 , THR B:223 , LYS B:224 , CYS B:225 , VAL B:226 , GLY B:235 , ARG B:236BINDING SITE FOR RESIDUE GOL B 580
72HC9SOFTWAREASN B:90 , GLY B:115 , SER B:116 , HOH B:834 , HOH B:839BINDING SITE FOR RESIDUE GOL B 586
73IC1SOFTWAREHIS B:209 , THR B:320 , LYS B:369 , ARG B:371 , HOH B:738 , HOH B:872BINDING SITE FOR RESIDUE GOL B 588
74IC2SOFTWARESER B:290 , GLY B:291 , CYS B:308 , HOH B:936BINDING SITE FOR RESIDUE GOL B 589
75IC3SOFTWARELEU A:87 , PHE A:89 , TYR B:91 , ASP B:142 , HIS B:144BINDING SITE FOR RESIDUE GOL B 607
76IC4SOFTWAREGLN B:218 , PRO B:219 , ASP B:404BINDING SITE FOR RESIDUE GOL B 598

(-) SS Bonds  (32, 32)

Asymmetric/Biological Unit
No.Residues
1A:8 -A:26
2A:126 -A:155
3A:159 -A:182
4A:169 -A:188
5A:192 -A:201
6A:196 -A:207
7A:208 -A:216
8A:212 -A:225
9A:228 -A:237
10A:241 -A:253
11A:259 -A:284
12A:266 -A:274
13A:288 -A:301
14A:304 -A:308
15A:312 -A:333
16A:435 -A:468
17B:8 -B:26
18B:126 -B:155
19B:159 -B:182
20B:169 -B:188
21B:192 -B:201
22B:196 -B:207
23B:208 -B:216
24B:212 -B:225
25B:228 -B:237
26B:241 -B:253
27B:259 -B:284
28B:266 -B:274
29B:288 -B:301
30B:304 -B:308
31B:312 -B:333
32B:435 -B:468

(-) Cis Peptide Bonds  (2, 2)

Asymmetric/Biological Unit
No.Residues
1Pro A:243 -Pro A:244
2Pro B:243 -Pro B:244

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (29, 58)

Asymmetric/Biological Unit (29, 58)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_004079N42KINSR_HUMANDisease (RMS)121913143A/BN15K
02UniProtVAR_004080V55AINSR_HUMANDisease (LEPRCH)121913152A/BV28A
03UniProtVAR_004081G58RINSR_HUMANDisease (LEPRCH)52836744A/BG31R
04UniProtVAR_015907D86GINSR_HUMANDisease (IRAN type A)  ---A/BD59G
05UniProtVAR_015908L89PINSR_HUMANDisease (IRAN type A)  ---A/BL62P
06UniProtVAR_004082R113PINSR_HUMANDisease (LEPRCH)121913153A/BR86P
07UniProtVAR_015909A119VINSR_HUMANDisease (LEPRCH)  ---A/BA92V
08UniProtVAR_031518L120QINSR_HUMANDisease (LEPRCH)  ---A/BL93Q
09UniProtVAR_015539I146MINSR_HUMANDisease (LEPRCH)121913159A/BI119M
10UniProtVAR_015910V167LINSR_HUMANDisease (IRAN type A)  ---A/BV140L
11UniProtVAR_058396Y171HINSR_HUMANPolymorphism1051692A/BH144H
12UniProtVAR_004083P220LINSR_HUMANPolymorphism749094324A/BP193L
13UniProtVAR_041429C228RINSR_HUMANUnclassified  ---A/BC201R
14UniProtVAR_004084H236RINSR_HUMANDisease (RMS)121913145A/BH209R
15UniProtVAR_004085L260PINSR_HUMANDisease (LEPRCH)121913141A/BL233P
16UniProtVAR_015540R279CINSR_HUMANDisease (IRAN type A)  ---A/BR252C
17UniProtVAR_031519R279HINSR_HUMANDisease (IRAN type A)  ---A/BR252H
18UniProtVAR_015911C280YINSR_HUMANDisease (IRAN type A)  ---A/BC253Y
19UniProtVAR_015912C301YINSR_HUMANDisease (LEPRCH)  ---A/BC274Y
20UniProtVAR_015914S350LINSR_HUMANDisease (RMS)  ---A/BS323L
21UniProtVAR_031520G386SINSR_HUMANDisease (RMS)764221583A/BG359S
22UniProtVAR_004086G393RINSR_HUMANDisease (LEPRCH)267607184A/BG366R
23UniProtVAR_004087F409VINSR_HUMANDisease (IRAN type A)121913142A/BF382V
24UniProtVAR_015542W439SINSR_HUMANDisease (LEPRCH)121913158A/BW412S
25UniProtVAR_015915I448TINSR_HUMANPolymorphism1051691A/BI421T
26UniProtVAR_031521N458DINSR_HUMANDisease (LEPRCH)121913160A/BN431D
27UniProtVAR_004088K487EINSR_HUMANDisease (LEPRCH)28933083A/BK460E
28UniProtVAR_004089N489SINSR_HUMANDisease (IRAN type A)28933085A/BN462S
29UniProtVAR_015916Q492KINSR_HUMANPolymorphism1131851A/BK465K

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (0, 0)

(no "PROSITE Motif" information available for 2HR7)

(-) Exons   (7, 14)

Asymmetric/Biological Unit (7, 14)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000003028501ENSE00001283493chr19:7294011-7293803209INSR_HUMAN1-34342A:4-7
B:4-7
4
4
1.2ENST000003028502ENSE00001157643chr19:7267907-7267356552INSR_HUMAN34-2181852A:7-191
B:7-191 (gaps)
185
185
1.3ENST000003028503ENSE00001157630chr19:7184648-7184327322INSR_HUMAN218-3251082A:191-298
B:191-298 (gaps)
108
108
1.4ENST000003028504ENSE00001157622chr19:7174742-7174594149INSR_HUMAN325-375512A:298-348
B:298-348
51
51
1.5ENST000003028505ENSE00001157620chr19:7172445-7172301145INSR_HUMAN375-423492A:348-396
B:348-396
49
49
1.6ENST000003028506ENSE00001157613chr19:7170762-7170548215INSR_HUMAN423-495732A:396-468
B:396-468
73
73
1.7ENST000003028507ENSE00001157603chr19:7168105-7167979127INSR_HUMAN495-537432A:468-469
B:468-470
2
3
1.8ENST000003028508ENSE00001157594chr19:7166415-7166165251INSR_HUMAN537-621850--
1.9ENST000003028509ENSE00001157586chr19:7163210-7163043168INSR_HUMAN621-677570--
1.10ENST0000030285010ENSE00001157582chr19:7152938-7152737202INSR_HUMAN677-744680--
1.11ENST0000030285011ENSE00001157509chr19:7150543-715050836INSR_HUMAN744-756130--
1.12ENST0000030285012ENSE00001157577chr19:7143101-7142827275INSR_HUMAN756-848930--
1.13ENST0000030285013ENSE00001157569chr19:7141827-7141688140INSR_HUMAN848-894470--
1.14ENST0000030285014ENSE00001157563chr19:7132328-7132169160INSR_HUMAN895-948540--
1.15ENST0000030285015ENSE00001157555chr19:7128965-7128863103INSR_HUMAN948-982350--
1.16ENST0000030285016ENSE00001157546chr19:7126662-712659568INSR_HUMAN982-1005240--
1.17ENST0000030285017ENSE00001157539chr19:7125538-7125294245INSR_HUMAN1005-1086820--
1.18ENST0000030285018ENSE00001157531chr19:7123000-7122890111INSR_HUMAN1087-1123370--
1.19ENST0000030285019ENSE00001157526chr19:7122784-7122625160INSR_HUMAN1124-1177540--
1.20ENST0000030285020ENSE00001686057chr19:7120760-7120631130INSR_HUMAN1177-1220440--
1.21ENST0000030285021ENSE00001157513chr19:7119594-7119460135INSR_HUMAN1220-1265460--
1.22ENST0000030285022ENSE00001383357chr19:7117421-71122665156INSR_HUMAN1265-13821180--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:466
 aligned with INSR_HUMAN | P06213 from UniProtKB/Swiss-Prot  Length:1382

    Alignment length:466
                                    40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490      
           INSR_HUMAN    31 PGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNYIVLNKDDNEECGDICPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHSECLGNCSQPDDPTKCVACRNFYLDGRCVETCPPPYYHFQDWRCVNFSFCQDLHHKCKNSRRQGCHQYVIHNNKCIPECPSGYTMNSSNLLCTPCLGPCPKVCHLLEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGYLKIRRSYALVSLSFFRKLRLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDQASCE 496
               SCOP domains d2hr7a1 A:4-156 automated matches                                                                                                                        d2hr7a2 A:157-311 automated matches                                                                                                                        d2hr7a3 A:312-469 automated matches                                                                                                                            SCOP domains
               CATH domains 2hr7A01 A:4-191 24 nucleotide stem-loop, u2 snrnp hairpin iv. U2 a'. Chain A, domain 1                                                                                                      2hr7A02 A:192-309 Hormone Receptor, Insulin-like Growth Factor Receptor 1; Chain A, domain 2                          2hr7A03 A:310-469 24 nucleotide stem-loop, u2 snrnp hairpin iv. U2 a'. Chain A, domain 1                                                                         CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeeeeeee..hhhhhhhh.eeeeeeeeeeeee...hhhhh.........ee...eeeeee..............ee........eeeeee..............ee...eeeeeee.........hhhhh.......eeeee.hhh...................eee..eee..eee..ee....hhhhh.................................eee..eee.......eee...eeehhhhhhhhhhhhhhh........eee..eee......eee......eee.......eeeeeeeeeee.hhhhhhh.....eeeeeeee......hhhhhhhhhhh...ee...eeee...............ee.........eeeeee................ee...eeeee.....hhhhhhhhhhhh....................... Sec.struct. author
             SAPs(SNPs) (1) -----------K------------A--R---------------------------G--P-----------------------P-----VQ-------------------------M--------------------L---H------------------------------------------------L-------R-------R-----------------------P------------------CY--------------------Y------------------------------------------------L-----------------------------------S------R---------------V-----------------------------S--------T---------D----------------------------E-S--K---- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------H------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) 1.1 ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.3  PDB: A:191-298 UniProt: 218-325                                                                   -------------------------------------------------Exon 1.5  PDB: A:348-396 UniProt: 375-423        -----------------------------------------------------------------------1. Transcript 1 (1)
           Transcript 1 (2) ---Exon 1.2  PDB: A:7-191 UniProt: 34-218                                                                                                                                                   ----------------------------------------------------------------------------------------------------------Exon 1.4  PDB: A:298-348 UniProt: 325-375          -----------------------------------------------Exon 1.6  PDB: A:396-468 UniProt: 423-495                                - Transcript 1 (2)
                 2hr7 A   4 PGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNHIVLNKDDNEECGDICPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHSECLGNCSQPDDPTKCVACRNFYLDGRCVETCPPPYYHFQDWRCVNFSFCQDLHHKCKNSRRQGCHQYVIHNNKCIPECPSGYTMNSSNLLCTPCLGPCPKVCHLLEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGYLKIRRSYALVSLSFFRKLRLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDKASCE 469
                                    13        23        33        43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453       463      

Chain B from PDB  Type:PROTEIN  Length:465
 aligned with INSR_HUMAN | P06213 from UniProtKB/Swiss-Prot  Length:1382

    Alignment length:467
                                    40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       
           INSR_HUMAN    31 PGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNYIVLNKDDNEECGDICPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHSECLGNCSQPDDPTKCVACRNFYLDGRCVETCPPPYYHFQDWRCVNFSFCQDLHHKCKNSRRQGCHQYVIHNNKCIPECPSGYTMNSSNLLCTPCLGPCPKVCHLLEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGYLKIRRSYALVSLSFFRKLRLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDQASCEN 497
               SCOP domains d2hr7b1 B:4-156 automated matches                                                                                                                        d2hr7b2 B :157-311 automated matches                                                                                                                       d2hr7b3 B:312-470 automated matches                                                                                                                             SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------2hr7B02 B:241-309                                                    2hr7B03 B:310-470 24 nucleotide stem-loop, u2 snrnp hairpin iv. U2 a'. Chain A, domain 1                                                                          CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeeeeeee..hhhhhhhh.eeeeeeeeeeeee...hhhhhh........ee...eeeeee..............ee........eeeeee..............ee...eeeee...........hhhhh.......eee.hhhhhh............-....eee....eee............hhhhh.................................eee..eee.......eee...eeehhhhhhhhhhhhhhh..-.....eee..eee......ee........ee.......eeeeeeeeeee.hhhhhhh.....eeeeeeee......hhhhhhhhhhh...ee...eeee...............ee.........eeeeee................ee...eeeee.....hhhhhhhhhhhh........................ Sec.struct. author
             SAPs(SNPs) (1) -----------K------------A--R---------------------------G--P-----------------------P-----VQ-------------------------M--------------------L---H------------------------------------------------L-------R-------R-----------------------P------------------CY--------------------Y------------------------------------------------L-----------------------------------S------R---------------V-----------------------------S--------T---------D----------------------------E-S--K----- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------H-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) 1.1 ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.3  PDB: B:191-298 (gaps) UniProt: 218-325                                                            -------------------------------------------------Exon 1.5  PDB: B:348-396 UniProt: 375-423        -----------------------------------------------------------------------1.7 Transcript 1 (1)
           Transcript 1 (2) ---Exon 1.2  PDB: B:7-191 (gaps) UniProt: 34-218                                                                                                                                            ----------------------------------------------------------------------------------------------------------Exon 1.4  PDB: B:298-348 UniProt: 325-375          -----------------------------------------------Exon 1.6  PDB: B:396-468 UniProt: 423-495                                -- Transcript 1 (2)
                 2hr7 B   4 PGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNHIVLNKDDNEECGDICPGTAKG-TNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHSECLGNCSQPDDPTKCVACRNFYLDGRCVETCPPPYYHFQDWRCVNFSFCQDLHHKCKNSRR-GCHQYVIHNNKCIPECPSGYTMNSSNLLCTPCLGPCPKVCHLLEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGYLKIRRSYALVSLSFFRKLRLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDKASCEN 470
                                    13        23        33        43        53        63        73        83        93       103       113       123       133       143       153       163 | |   173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453       463       
                                                                                                                                                                                           165 |                                                                                                     271 |                                                                                                                                                                                                     
                                                                                                                                                                                             167                                                                                                       273                                                                                                                                                                                                     

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 6)

Asymmetric/Biological Unit

(-) CATH Domains  (2, 5)

Asymmetric/Biological Unit
(-)
Class: Alpha Beta (26913)
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2HR7)

(-) Gene Ontology  (98, 98)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A,B   (INSR_HUMAN | P06213)
molecular function
    GO:0043423    3-phosphoinositide-dependent protein kinase binding    Interacting selectively and non-covalently with a 3-phosphoinositide-dependent protein kinase.
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0005525    GTP binding    Interacting selectively and non-covalently with GTP, guanosine triphosphate.
    GO:0051425    PTB domain binding    Interacting selectively and non-covalently with a phosphotyrosine-binding (PTB) domain of a protein.
    GO:0043559    insulin binding    Interacting selectively and non-covalently with insulin, a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
    GO:0043560    insulin receptor substrate binding    Interacting selectively and non-covalently with any of the insulin receptor substrate (IRS) proteins, adaptor proteins that bind to the transphosphorylated insulin and insulin-like growth factor receptors, are themselves phosphorylated and in turn recruit SH2 domain-containing signaling molecules to form a productive signaling complex.
    GO:0005009    insulin-activated receptor activity    Combining with insulin and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0031994    insulin-like growth factor I binding    Interacting selectively and non-covalently with insulin-like growth factor I.
    GO:0031995    insulin-like growth factor II binding    Interacting selectively and non-covalently with insulin-like growth factor II.
    GO:0005159    insulin-like growth factor receptor binding    Interacting selectively and non-covalently with the insulin-like growth factor receptor.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0031405    lipoic acid binding    Interacting selectively and non-covalently with lipoic acid, 1,2-dithiolane-3-pentanoic acid.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0043548    phosphatidylinositol 3-kinase binding    Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0032403    protein complex binding    Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0019904    protein domain specific binding    Interacting selectively and non-covalently with a specific domain of a protein.
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0019901    protein kinase binding    Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
    GO:0019903    protein phosphatase binding    Interacting selectively and non-covalently with any protein phosphatase.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0004716    signal transducer, downstream of receptor, with protein tyrosine kinase activity    Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
    GO:0007186    G-protein coupled receptor signaling pathway    A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
    GO:0000187    activation of MAPK activity    The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
    GO:0032148    activation of protein kinase B activity    Any process that initiates the activity of the inactive enzyme protein kinase B.
    GO:0032147    activation of protein kinase activity    Any process that initiates the activity of an inactive protein kinase.
    GO:0030325    adrenal gland development    The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells.
    GO:0009887    animal organ morphogenesis    Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
    GO:0005975    carbohydrate metabolic process    The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.
    GO:0071363    cellular response to growth factor stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
    GO:0032869    cellular response to insulin stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
    GO:0008544    epidermis development    The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
    GO:0031017    exocrine pancreas development    The process whose specific outcome is the progression of the exocrine pancreas over time, from its formation to the mature structure. The exocrine pancreas produces and store zymogens of digestive enzymes, such as chymotrypsinogen and trypsinogen in the acinar cells.
    GO:0045444    fat cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
    GO:0042593    glucose homeostasis    Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
    GO:0003007    heart morphogenesis    The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
    GO:0008286    insulin receptor signaling pathway    The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
    GO:0008584    male gonad development    The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
    GO:0030238    male sex determination    The specification of male sex of an individual organism.
    GO:0010629    negative regulation of gene expression    Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0001933    negative regulation of protein phosphorylation    Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
    GO:0032410    negative regulation of transporter activity    Any process that stops or reduces the activity of a transporter.
    GO:0038083    peptidyl-tyrosine autophosphorylation    The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0045740    positive regulation of DNA replication    Any process that activates or increases the frequency, rate or extent of DNA replication.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0048639    positive regulation of developmental growth    Any process that activates, maintains or increases the rate of developmental growth.
    GO:0046326    positive regulation of glucose import    Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
    GO:0045725    positive regulation of glycogen biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
    GO:0045821    positive regulation of glycolytic process    Any process that activates or increases the frequency, rate or extent of glycolysis.
    GO:0010560    positive regulation of glycoprotein biosynthetic process    Any process that increases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
    GO:0051446    positive regulation of meiotic cell cycle    Any process that activates or increases the frequency, rate or extent of progression through the meiotic cell cycle.
    GO:0045840    positive regulation of mitotic nuclear division    Any process that activates or increases the frequency, rate or extent of mitosis.
    GO:0045429    positive regulation of nitric oxide biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
    GO:0051897    positive regulation of protein kinase B signaling    Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:0060267    positive regulation of respiratory burst    Any process that increases the rate frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
    GO:0045893    positive regulation of transcription, DNA-templated    Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0051290    protein heterotetramerization    The formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical.
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0045995    regulation of embryonic development    Any process that modulates the frequency, rate or extent of embryonic development.
    GO:2000194    regulation of female gonad development    Any process that modulates the frequency, rate or extent of female gonad development.
    GO:0010310    regulation of hydrogen peroxide metabolic process    Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide.
    GO:0006355    regulation of transcription, DNA-templated    Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0014823    response to activity    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus.
    GO:0032355    response to estradiol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
    GO:0045471    response to ethanol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
    GO:0051384    response to glucocorticoid    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
    GO:0009725    response to hormone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
    GO:0032868    response to insulin    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
    GO:0010042    response to manganese ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a manganese ion stimulus.
    GO:0031667    response to nutrient levels    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
    GO:0033574    response to testosterone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.
    GO:0034612    response to tumor necrosis factor    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
    GO:0033280    response to vitamin D    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.
    GO:0023014    signal transduction by protein phosphorylation    A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
    GO:0019087    transformation of host cell by virus    Any virus-induced change in the morphological, biochemical, or growth parameters of a cell.
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0005901    caveola    A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0010008    endosome membrane    The lipid bilayer surrounding an endosome.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005899    insulin receptor complex    A disulfide-bonded, heterotetrameric receptor complex. The alpha chains are entirely extracellular, while each beta chain has one transmembrane domain. The ligand binds to the alpha subunit extracellular domain and the kinase is associated with the beta subunit intracellular domain.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0043231    intracellular membrane-bounded organelle    Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0045202    synapse    The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    BMA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FUC  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    GOL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    MAN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    P33  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    AD1  [ RasMol ]  +environment [ RasMol ]
    AD2  [ RasMol ]  +environment [ RasMol ]
    AD3  [ RasMol ]  +environment [ RasMol ]
    AD4  [ RasMol ]  +environment [ RasMol ]
    AD5  [ RasMol ]  +environment [ RasMol ]
    AD6  [ RasMol ]  +environment [ RasMol ]
    AD7  [ RasMol ]  +environment [ RasMol ]
    AD8  [ RasMol ]  +environment [ RasMol ]
    AD9  [ RasMol ]  +environment [ RasMol ]
    AE1  [ RasMol ]  +environment [ RasMol ]
    AE2  [ RasMol ]  +environment [ RasMol ]
    AE3  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    CC2  [ RasMol ]  +environment [ RasMol ]
    CC3  [ RasMol ]  +environment [ RasMol ]
    CC4  [ RasMol ]  +environment [ RasMol ]
    CC6  [ RasMol ]  +environment [ RasMol ]
    CC7  [ RasMol ]  +environment [ RasMol ]
    DC2  [ RasMol ]  +environment [ RasMol ]
    DC3  [ RasMol ]  +environment [ RasMol ]
    DC4  [ RasMol ]  +environment [ RasMol ]
    DC6  [ RasMol ]  +environment [ RasMol ]
    DC9  [ RasMol ]  +environment [ RasMol ]
    EC1  [ RasMol ]  +environment [ RasMol ]
    EC2  [ RasMol ]  +environment [ RasMol ]
    EC3  [ RasMol ]  +environment [ RasMol ]
    EC4  [ RasMol ]  +environment [ RasMol ]
    EC5  [ RasMol ]  +environment [ RasMol ]
    EC6  [ RasMol ]  +environment [ RasMol ]
    EC7  [ RasMol ]  +environment [ RasMol ]
    EC8  [ RasMol ]  +environment [ RasMol ]
    EC9  [ RasMol ]  +environment [ RasMol ]
    FC1  [ RasMol ]  +environment [ RasMol ]
    FC2  [ RasMol ]  +environment [ RasMol ]
    FC3  [ RasMol ]  +environment [ RasMol ]
    FC4  [ RasMol ]  +environment [ RasMol ]
    FC5  [ RasMol ]  +environment [ RasMol ]
    FC6  [ RasMol ]  +environment [ RasMol ]
    FC7  [ RasMol ]  +environment [ RasMol ]
    FC8  [ RasMol ]  +environment [ RasMol ]
    FC9  [ RasMol ]  +environment [ RasMol ]
    GC1  [ RasMol ]  +environment [ RasMol ]
    GC2  [ RasMol ]  +environment [ RasMol ]
    GC3  [ RasMol ]  +environment [ RasMol ]
    GC4  [ RasMol ]  +environment [ RasMol ]
    GC5  [ RasMol ]  +environment [ RasMol ]
    GC6  [ RasMol ]  +environment [ RasMol ]
    GC7  [ RasMol ]  +environment [ RasMol ]
    GC8  [ RasMol ]  +environment [ RasMol ]
    GC9  [ RasMol ]  +environment [ RasMol ]
    HC1  [ RasMol ]  +environment [ RasMol ]
    HC3  [ RasMol ]  +environment [ RasMol ]
    HC4  [ RasMol ]  +environment [ RasMol ]
    HC5  [ RasMol ]  +environment [ RasMol ]
    HC6  [ RasMol ]  +environment [ RasMol ]
    HC7  [ RasMol ]  +environment [ RasMol ]
    HC8  [ RasMol ]  +environment [ RasMol ]
    HC9  [ RasMol ]  +environment [ RasMol ]
    IC1  [ RasMol ]  +environment [ RasMol ]
    IC2  [ RasMol ]  +environment [ RasMol ]
    IC3  [ RasMol ]  +environment [ RasMol ]
    IC4  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Pro A:243 - Pro A:244   [ RasMol ]  
    Pro B:243 - Pro B:244   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2hr7
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  INSR_HUMAN | P06213
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.1.112
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  246200
    Disease InformationOMIM
  262190
    Disease InformationOMIM
  610549
    Disease InformationOMIM
 
Access by GenAge ID
  0042
    Age Related InformationGenAge
  0109
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  INSR_HUMAN | P06213
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        INSR_HUMAN | P062131gag 1i44 1ir3 1irk 1p14 1rqq 2auh 2b4s 2mfr 2z8c 3bu3 3bu5 3bu6 3ekk 3ekn 3eta 3w11 3w12 3w13 3w14 4ibm 4oga 4xlv 4xss 4xst 4zxb 5e1s 5hhw 5j3h

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 2HR7)